| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Wainman Paul R is a Director at ICCC. Recent filings cover 1 purchase and 0 sales. Those positions are worth an estimated $30K at current prices.
Wainman Paul R's largest disclosed position is in ICCC as Director, worth about $30K. Net of sales, the recent Form 4 record there shows accumulation of 175 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2015 | ICCC Immucell Corp /de/ | Director | Buy | 175 | $6.80 | $1,189.98 | +9.6% |